Mycoplasma pneumonia
Mycoplasma pneumonia is pneumonia caused by Mycoplasma pneumonia (MP), formerly known as primary atypical pneumonia. The onset is slow, with fever, paroxysmal irritating cough, and a small amount of mucous or mucopurulent sputum (occasionally bloody sputum). Pulmonary signs are mostly not obvious, but it is easy to cause multi-system involvement outside the lungs, and can also threaten life or death. It is common in children or adolescents, accounting for about 15% to 30% of the total number of pneumonia, and can be as high as 40% to 60% in an epidemic year; the prognosis is generally good, and it is a self-limiting disease.
Related Drugs
Midecamycin Capsules
Indication: It is mainly suitable for respiratory tract infections and skin, soft tissue and bile tract infections caused by Staphylococcus aureus, hemolytic Streptococcus, Pneumococcus, etc., and can also be used for Mycoplasma pneumonia.
Midecamycin Capsules
Indication: It is mainly suitable for respiratory tract infections and skin, soft tissue and bile tract infections caused by Staphylococcus aureus, hemolytic Streptococcus, Pneumococcus, etc., and can also be used for Mycoplasma pneumonia.
Manufacturer:
Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.
Midecamycin Capsules
Indication: It is mainly suitable for respiratory tract infections and skin, soft tissue and bile tract infections caused by Staphylococcus aureus, hemolytic Streptococcus, Pneumococcus, etc., and can also be used for Mycoplasma pneumonia.
Midecamycin Capsules
Indication: It is mainly suitable for respiratory tract infections and skin, soft tissue and bile tract infections caused by Staphylococcus aureus, hemolytic Streptococcus, Pneumococcus, etc., and can also be used for Mycoplasma pneumonia.
Midecamycin Capsules
Indication: It is mainly suitable for respiratory tract infections and skin, soft tissue and bile tract infections caused by Staphylococcus aureus, hemolytic Streptococcus, Pneumococcus, etc., and can also be used for Mycoplasma pneumonia.
Erdosteine Capsules
Indication: Suitable for acute and chronic bronchitis, and respiratory obstruction caused by thick sputum.
Manufacturer:
XI'AN HAIXIN Pharmaceutical Co., Ltd.
Dirithromycin Enteric-coated Capsules
Indication: This product is a broad-spectrum macrolide antibiotic, suitable for patients over 12 years old, used to treat mild and moderate infections caused by the following sensitive bacteria: Acute exacerbation of chronic bronchitis: caused by Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae. Acute bronchitis: caused by Moraxella catarrhalis and Streptococcus pneumoniae. Community-acquired pneumonia: caused by Legionella pneumophila, Mycoplasma pneumoniae, and Streptococcus pneumoniae. Nasopharyngitis and tonsillitis: caused by Streptococcus pyogenes. Simple skin and soft tissue infections: caused by Staphylococcus aureus (methicillin-sensitive strains) and Streptococcus pyogenes.
Manufacturer:
Sichuan Hexin Pharmaceutical Co., Ltd.
Cough tablets
Manufacturer:
Jilin Kangfu Pharmaceutical Co., Ltd.
Roxithromycin dry suspension
Indication: 1. Suitable for the following infections caused by sensitive strains: (1) Upper respiratory tract infection. (2) Lower respiratory tract infection. (3) Ear, nose and throat infection. (4) Genital infection (except gonococcal infection). (5) Skin and soft tissue infection. 2. Can also be used for mycoplasma pneumonia, Chlamydia trachomatis infection and Legionnaires' disease, etc.
Manufacturer:
Harbin SUNSHINE Pharmaceutical Co., Ltd.
Roxithromycin dry suspension
Indication: 1. Suitable for the following infections caused by sensitive strains: (1) Upper respiratory tract infection. (2) Lower respiratory tract infection. (3) Ear, nose and throat infection. (4) Genital infection (except gonococcal infection). (5) Skin and soft tissue infection. 2. Can also be used for mycoplasma pneumonia, Chlamydia trachomatis infection and Legionnaires' disease, etc.
Manufacturer:
Harbin SUNSHINE Pharmaceutical Co., Ltd.